Boxer Capital Management, LLC / NKTR
Boxer Capital Management, LLC’s Nektar Therapeutics Position
Does Boxer Capital Management, LLC own Nektar Therapeutics (NKTR)? Not currently — the last reported position was 125.0K shares worth $7M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$7M
Q3 2025
Shares
125.0K
% of Portfolio
+2.27%
Quarters Held
2
position exited
Position History NKTR
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital Management, LLC’s full portfolio or all institutional holders of NKTR.